Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2011 Filed Feb 28, 2011 23:51 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
GrantCommon Stock | 866 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-007686 · doc4.xml · nonDerivative · entry 2 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,854 F2 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 24, 2011 Filed Feb 28, 2011 23:51 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
GrantCommon Stock | 12,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-007686 · doc4.xml · nonDerivative · entry 1 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,988 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 24, 2011 Filed Feb 28, 2011 23:55 UTC |
Lewis-Hall Freda CExecutive Vice President
|
GrantStock Appreciation Rights · Derivative | 91,876 | $0.00 Strike: $18.90 | $0.00 |
DisclosureSEC source: 0001225208-11-007687 · doc4.xml · derivative · entry 4 Lewis-Hall Freda C · CIK 0001437909 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,876 Underlying: Common Stock · 91,876 shares Expires 2018-02-24 F3 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F3 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 24, 2011 Filed Feb 28, 2011 23:55 UTC |
Lewis-Hall Freda CExecutive Vice President
|
GrantStock Appreciation Rights · Derivative | 110,981 | $0.00 Strike: $18.90 | $0.00 |
DisclosureSEC source: 0001225208-11-007687 · doc4.xml · derivative · entry 3 Lewis-Hall Freda C · CIK 0001437909 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,981 Underlying: Common Stock · 110,981 shares Expires 2016-02-24 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 24, 2011 Filed Feb 28, 2011 23:55 UTC |
Lewis-Hall Freda CExecutive Vice President
|
GrantCommon Stock | 39,439 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-007687 · doc4.xml · nonDerivative · entry 1 Lewis-Hall Freda C · CIK 0001437909 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,354 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 24, 2011 Filed Mar 1, 2011 00:02 UTC |
PECK KRISTIN CExecutive Vice President
|
GrantStock Appreciation Rights · Derivative | 28,288 | $0.00 Strike: $18.90 | $0.00 |
DisclosureSEC source: 0001225208-11-007688 · doc4.xml · derivative · entry 6 PECK KRISTIN C · CIK 0001488267 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,288 Underlying: Common Stock · 28,288 shares Expires 2018-02-24 F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 24, 2011 Filed Mar 1, 2011 00:02 UTC |
PECK KRISTIN CExecutive Vice President
|
GrantStock Appreciation Rights · Derivative | 34,171 | $0.00 Strike: $18.90 | $0.00 |
DisclosureSEC source: 0001225208-11-007688 · doc4.xml · derivative · entry 5 PECK KRISTIN C · CIK 0001488267 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,171 Underlying: Common Stock · 34,171 shares Expires 2016-02-24 F4 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F4 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 24, 2011 Filed Mar 1, 2011 00:02 UTC |
PECK KRISTIN CExecutive Vice President
|
Tax withholdingCommon Stock | 453 | $18.90 | $8,561.70 |
DisclosureSEC source: 0001225208-11-007688 · doc4.xml · nonDerivative · entry 3 PECK KRISTIN C · CIK 0001488267 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,795 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 24, 2011 Filed Mar 1, 2011 00:02 UTC |
PECK KRISTIN CExecutive Vice President
|
GrantCommon Stock | 1,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-007688 · doc4.xml · nonDerivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,248 F2 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 24, 2011 Filed Mar 1, 2011 00:02 UTC |
PECK KRISTIN CExecutive Vice President
|
GrantCommon Stock | 7,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-007688 · doc4.xml · nonDerivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,130 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 24, 2011 Filed Mar 1, 2011 00:07 UTC |
Redmond Cavan M.Group President
|
GrantStock Appreciation Rights · Derivative | 91,876 | $0.00 Strike: $18.90 | $0.00 |
DisclosureSEC source: 0001225208-11-007689 · doc4.xml · derivative · entry 4 Redmond Cavan M. · CIK 0001420120 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,876 Underlying: Common Stock · 91,876 shares Expires 2018-02-24 F3 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F3 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 24, 2011 Filed Mar 1, 2011 00:07 UTC |
Redmond Cavan M.Group President
|
GrantStock Appreciation Rights · Derivative | 110,981 | $0.00 Strike: $18.90 | $0.00 |
DisclosureSEC source: 0001225208-11-007689 · doc4.xml · derivative · entry 3 Redmond Cavan M. · CIK 0001420120 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,981 Underlying: Common Stock · 110,981 shares Expires 2016-02-24 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 24, 2011 Filed Mar 1, 2011 00:07 UTC |
Redmond Cavan M.Group President
|
GrantCommon Stock | 37,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-007689 · doc4.xml · nonDerivative · entry 1 Redmond Cavan M. · CIK 0001420120 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,263 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 24, 2011 Filed Mar 1, 2011 00:26 UTC |
RICCIARDI NATALE SSenior Vice President
|
Tax withholdingCommon Stock | 1,961 | $18.90 | $37,062.90 |
DisclosureSEC source: 0001225208-11-007693 · doc4.xml · nonDerivative · entry 3 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 402,502 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 24, 2011 Filed Mar 1, 2011 00:26 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantCommon Stock | 5,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-007693 · doc4.xml · nonDerivative · entry 2 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,463 F2 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 24, 2011 Filed Mar 1, 2011 00:26 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantCommon Stock | 10,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-007693 · doc4.xml · nonDerivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,951 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 24, 2011 Filed Mar 1, 2011 01:40 UTC |
SUSMAN SALLYExecutive Vice President
|
GrantStock Appreciation Rights · Derivative | 91,876 | $0.00 Strike: $18.90 | $0.00 |
DisclosureSEC source: 0001225208-11-007704 · doc4.xml · derivative · entry 6 SUSMAN SALLY · CIK 0001263544 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,876 Underlying: Common Stock · 91,876 shares Expires 2018-02-24 F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 24, 2011 Filed Mar 1, 2011 01:40 UTC |
SUSMAN SALLYExecutive Vice President
|
GrantStock Appreciation Rights · Derivative | 110,981 | $0.00 Strike: $18.90 | $0.00 |
DisclosureSEC source: 0001225208-11-007704 · doc4.xml · derivative · entry 5 SUSMAN SALLY · CIK 0001263544 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,981 Underlying: Common Stock · 110,981 shares Expires 2016-02-24 F4 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F4 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 24, 2011 Filed Mar 1, 2011 01:40 UTC |
SUSMAN SALLYExecutive Vice President
|
Tax withholdingCommon Stock | 1,937 | $18.90 | $36,609.30 |
DisclosureSEC source: 0001225208-11-007704 · doc4.xml · nonDerivative · entry 3 SUSMAN SALLY · CIK 0001263544 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,341 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 24, 2011 Filed Mar 1, 2011 01:40 UTC |
SUSMAN SALLYExecutive Vice President
|
GrantCommon Stock | 4,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-007704 · doc4.xml · nonDerivative · entry 2 SUSMAN SALLY · CIK 0001263544 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,278 F2 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 24, 2011 Filed Mar 1, 2011 01:40 UTC |
SUSMAN SALLYExecutive Vice President
|
GrantCommon Stock | 38,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-007704 · doc4.xml · nonDerivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,552 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 24, 2011 Filed Mar 1, 2011 15:54 UTC Amendment |
SCHULMAN AMY WExecutive Vice President
|
GrantStock Appreciation Rights · Derivative | 145,068 | $0.00 Strike: $18.90 | $0.00 |
DisclosureSEC source: 0001223203-11-000006 · primary_doc.xml · derivative · entry 2 SCHULMAN AMY W · CIK 0001438226 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,068 Underlying: Common Stock · 145,068 shares Expires 2018-02-24 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 24, 2011 Filed Mar 1, 2011 15:54 UTC Amendment |
SCHULMAN AMY WExecutive Vice President
|
GrantStock Appreciation Rights · Derivative | 175,234 | $0.00 Strike: $18.90 | $0.00 |
DisclosureSEC source: 0001223203-11-000006 · primary_doc.xml · derivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,234 Underlying: Common Stock · 175,234 shares Expires 2016-02-24 F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 23, 2011 Filed Feb 24, 2011 18:28 UTC |
BRANDICOURT OLIVIERBusiness Unit President
|
Tax withholdingCommon Stock | 641 | $18.76 | $12,025.16 |
DisclosureSEC source: 0001225208-11-007056 · doc4.xml · nonDerivative · entry 1 BRANDICOURT OLIVIER · CIK 0001508518 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,278 F1 · kind: Represents withholding of shares to satisfy tax obligations upon vesting of restricted stock units. Read SEC document |
| February 23, 2011 Filed Feb 24, 2011 18:30 UTC |
HILL CHARLES HExecutive Vice President
|
Tax withholdingCommon Stock | 508 | $18.76 | $9,530.08 |
DisclosureSEC source: 0001225208-11-007057 · doc4.xml · nonDerivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,678 F1 · kind: Represents withholding of shares to satisfy tax obligations upon vesting of restricted stock units. Read SEC document |
| February 23, 2011 Filed Feb 24, 2011 18:32 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
Tax withholdingCommon Stock | 435 | $18.76 | $8,160.60 |
DisclosureSEC source: 0001225208-11-007060 · doc4.xml · nonDerivative · entry 1 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,611 F1 · kind: Represents withholding of shares to satisfy tax obligations upon vesting of restricted stock units. Read SEC document |
| February 23, 2011 Filed Feb 24, 2011 18:33 UTC |
PECK KRISTIN CExecutive Vice President
|
Tax withholdingCommon Stock | 176 | $18.76 | $3,301.76 |
DisclosureSEC source: 0001225208-11-007061 · doc4.xml · nonDerivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,388 F1 · kind: Represents withholding of shares to satisfy tax obligations upon vesting of restricted stock units. Read SEC document |
| February 23, 2011 Filed Feb 24, 2011 18:34 UTC |
SIMMONS DAVID SBusiness Unit President
|
Tax withholdingCommon Stock | 315 | $18.76 | $5,909.40 |
DisclosureSEC source: 0001225208-11-007062 · doc4.xml · nonDerivative · entry 1 SIMMONS DAVID S · CIK 0001508519 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,774 F1 · kind: Represents withholding of shares to satisfy tax obligations upon vesting of restricted stock units. Read SEC document |
| February 08, 2011 Filed Feb 9, 2011 16:36 UTC |
CORNWELL W DONDirector
|
SaleCommon Stock | 100 | $19.05 | $1,905.00 |
DisclosureSEC source: 0001225208-11-005059 · doc4.xml · nonDerivative · entry 2 CORNWELL W DON · CIK 0001174477 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 300 F1 · ownership.nature: The reporting person disclaims beneficial ownership of the shares held by spouse. Read SEC document |
| February 08, 2011 Filed Feb 9, 2011 16:36 UTC |
CORNWELL W DONDirector
|
PurchaseCommon Stock | 100 | $19.05 | $1,905.00 |
DisclosureSEC source: 0001225208-11-005059 · doc4.xml · nonDerivative · entry 1 CORNWELL W DON · CIK 0001174477 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,700 Read SEC document |
| January 31, 2011 Filed Feb 1, 2011 21:30 UTC |
SIMMONS DAVID SBusiness Unit President
|
Tax withholdingCommon Stock | 4,331 | $18.22 | $78,910.82 |
DisclosureSEC source: 0001225208-11-004432 · doc4.xml · nonDerivative · entry 1 SIMMONS DAVID S · CIK 0001508519 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,291 F1 · kind: Represents withholding of shares to satisfy tax obligations upon vesting of restricted stock units. Read SEC document |
| January 31, 2011 Filed Feb 1, 2011 21:32 UTC |
STEERE WILLIAM C JRDirector
|
Tax withholdingCommon Stock | 54,992 | $18.22 | $1,001,954.24 |
DisclosureSEC source: 0001225208-11-004434 · doc4.xml · nonDerivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,265,131 F1 · kind: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the distribution of shares previously earned out under the Performance-Contingent Share Award Program. Read SEC document |
| December 31, 2010 Filed Jan 3, 2011 21:51 UTC |
BRANDICOURT OLIVIERBusiness Unit President
|
GrantPhantom Stock Units SSP · Derivative | 91 | $17.51 | $1,593.41 |
DisclosureSEC source: 0001225208-11-000228 · doc4.xml · derivative · entry 1 BRANDICOURT OLIVIER · CIK 0001508518 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,665 Underlying: Common Stock · 91 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2010 Filed Jan 3, 2011 21:55 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 64 | $17.51 | $1,120.64 |
DisclosureSEC source: 0001225208-11-000230 · doc4.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,717 Underlying: Common Stock · 64 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2010 Filed Jan 3, 2011 22:01 UTC |
DAMELIO FRANK AExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 117 | $17.51 | $2,048.67 |
DisclosureSEC source: 0001225208-11-000235 · doc4.xml · derivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,241 Underlying: Common Stock · 117 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2010 Filed Jan 3, 2011 22:05 UTC |
HILL CHARLES HExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 49 | $17.51 | $857.99 |
DisclosureSEC source: 0001225208-11-000237 · doc4.xml · derivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352 Underlying: Common Stock · 49 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2010 Filed Jan 3, 2011 22:07 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 113 | $17.51 | $1,978.63 |
DisclosureSEC source: 0001225208-11-000239 · doc4.xml · derivative · entry 1 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,213 Underlying: Common Stock · 113 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2010 Filed Jan 3, 2011 22:10 UTC |
Lewis-Hall Freda CExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 95 | $17.51 | $1,663.45 |
DisclosureSEC source: 0001225208-11-000241 · doc4.xml · derivative · entry 1 Lewis-Hall Freda C · CIK 0001437909 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,206 Underlying: Common Stock · 95 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2010 Filed Jan 3, 2011 22:13 UTC |
PECK KRISTIN CExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 48 | $17.51 | $840.48 |
DisclosureSEC source: 0001225208-11-000243 · doc4.xml · derivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,760 Underlying: Common Stock · 48 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2010 Filed Jan 3, 2011 22:18 UTC |
READ IAN CDirector · President & CEO
|
GrantPhantom Stock Units SSP · Derivative | 290 | $17.51 | $5,077.90 |
DisclosureSEC source: 0001225208-11-000269 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,197 Underlying: Common Stock · 290 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2010 Filed Jan 3, 2011 22:20 UTC |
SIMMONS DAVID SBusiness Unit President
|
GrantPhantom Stock Units SSP · Derivative | 74 | $17.51 | $1,295.74 |
DisclosureSEC source: 0001225208-11-000280 · doc4.xml · derivative · entry 1 SIMMONS DAVID S · CIK 0001508519 · Business Unit President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,050 Underlying: Common Stock · 74 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2010 Filed Jan 3, 2011 22:25 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 76 | $17.51 | $1,330.76 |
DisclosureSEC source: 0001225208-11-000281 · doc4.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,897 Underlying: Common Stock · 76 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2010 Filed Jan 3, 2011 22:28 UTC |
SUSMAN SALLYExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 85 | $17.51 | $1,488.35 |
DisclosureSEC source: 0001225208-11-000283 · doc4.xml · derivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,915 Underlying: Common Stock · 85 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2010 Filed Jan 3, 2011 22:31 UTC |
SCHULMAN AMY WExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 90 | $17.51 | $1,575.90 |
DisclosureSEC source: 0001225208-11-000284 · doc4.xml · derivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,963 Underlying: Common Stock · 90 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2010 Filed Jan 3, 2011 23:54 UTC |
KILTS JAMES MDirector
|
GrantPhantom Stock Units · Derivative | 1,958 | $17.51 | $34,284.58 |
DisclosureSEC source: 0001225208-11-000298 · doc4.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,002 Underlying: Common Stock · 1,958 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 31, 2010 Filed Jan 3, 2011 23:55 UTC |
STEERE WILLIAM C JRDirector
|
GrantPhantom Stock Units · Derivative | 1,697 | $17.51 | $29,714.47 |
DisclosureSEC source: 0001225208-11-000299 · doc4.xml · derivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,538 Underlying: Common Stock · 1,697 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 31, 2010 Filed Jan 3, 2011 23:57 UTC |
SANGER STEPHEN WDirector
|
GrantPhantom Stock Units · Derivative | 1,949 | $17.51 | $34,126.99 |
DisclosureSEC source: 0001225208-11-000300 · doc4.xml · derivative · entry 1 SANGER STEPHEN W · CIK 0001204994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,059 Underlying: Common Stock · 1,949 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 15, 2010 Filed Dec 17, 2010 20:41 UTC |
MCLEOD MARY SFormer Sr. Vice President
|
GrantPhantom Stock Units SSP · Derivative | 80 | $17.08 | $1,366.40 |
DisclosureSEC source: 0001225208-10-027358 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Former Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,605 Underlying: Common Stock · 80 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 15, 2010 Filed Dec 17, 2010 20:57 UTC |
KINDLER JEFFREY BDirector · Former Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 261 | $17.08 | $4,457.88 |
DisclosureSEC source: 0001225208-10-027361 · doc4.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Former Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,194 Underlying: Common Stock · 261 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 15, 2010 Filed Dec 17, 2010 21:06 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 66 | $17.08 | $1,127.28 |
DisclosureSEC source: 0001225208-10-027364 · doc4.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,653 Underlying: Common Stock · 66 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.